Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by BearDownAZ


T.RVX

RE:Post January

"...if we have success in this trial we still need to do one more phase...

September 27, 2018

V.BTI.H

RE:BrearDown

Well, Amarin (Vascepa) and Astrazeneca (Epanova) have had their products...

September 24, 2018

V.BTI.H

RE:Forum Effects and Challenges

Amazing post JD!

September 23, 2018

V.BTI.H

RE:RE:RE:Craziest page of posts ever!!

"The noisy ones make a lot of noise, but most of the investors here are...

September 14, 2018

T.RVX

RE:Zenith

I don't post here often anymore, but anthonyevans' dig at Agoracom...

September 11, 2018

V.BTI.H

RE:RVX up 66% in one month and one week since

Also up 368% since end of May.

September 7, 2018

V.BTI.H

RE:RE:Ossianix - Novo Nordisk

Mark Day recently mentioned Ossianix as a company still working on...

September 5, 2018

T.RVX

RE:Message to BearDownAZ

Ron, Check your Stockhouse PM inbox. It wasn't any of us RVX/Zenith...

August 27, 2018

ESPR

Positive Phase 3 Results for Bempedoic Acid/Ezetimibe Combo

Esperion Announces Positive Top-Line Results from Pivotal Phase 3 Bempedoic...

August 27, 2018

ESPR

ESPR Presents Final Results of Phase 3 Study 1 at ESC 2018

Esperion Announces Late-Breaking Oral Presentation of Final Results of Phase...

August 26, 2018

ESPR

Esperion to Host Analyst and Investor Day Event on July 10

Esperion to Host Analyst and Investor Day Event on July 10 http://investor...

July 3, 2018

V.BTI.H

biOasis Agoracom Forum

If anyone here on the biOasis Stockhouse forum is looking for a different...

June 21, 2018

ESPR

Full Study 4 Results Presented in Oral Session at IAS 2018

Esperion Announces Late-Breaking Oral Presentation of Full Study 4 Results...

June 12, 2018

V.BTI.H

RE:Up Dated Corporate Presentation

Here is the direct link to the BIO International Slide Deck.

June 12, 2018

ESPR

New June 2018 Esperion Hearts and Minds Blog

Esperion posted a new Hearts and Minds blog today in which Tim Mayleben...

June 6, 2018

V.BTI.H

RE:RE:RE:RE:RE:Tomorrow: 2018 BIO International Convention

Mark Day from BiOasis presents at BIO International Tuesday June 5th 11:15 AM...

June 5, 2018

V.BTI.H

RE:RE:RE:RE:RE:RE:RE:RE:Bioasis announces independent research publication in JCBFM

The prospects for non-intravenous delivery of xB3 payloads are pretty good in...

May 30, 2018

V.BTI.H

RE:RE:RE:RE:RE:RE:Bioasis announces independent research publication in JCBFM

Yes, Alnylam with siRNA and IONIS with antisense oligonucleotides (ASOs) are...

May 30, 2018

V.BTI.H

RE:RE:RE:RE:Bioasis announces independent research publication in JCBFM

A few other observations from the paper: Reference 21 is cited as...

May 30, 2018

V.BTI.H

RE:RE:RE:Bioasis announces independent research publication in JCBFM

Minedigger, Medimmune is part of Astrazeneca. BearDownAZ

May 30, 2018